+ Watch VAR
on My Watchlist
The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.
Varian is sporting high returns on capital, and its earnings appear to be quality in nature (operating cash flow is keeping pace with net income). I like how sales, earnings, and book value are growing, and I think I'm getting this for a fair price at $71.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions